Clinical trial
Bosentan in Treatment of Pulmonary Arterial Hypertension
NCT00266162 · Competence Network for Congenital Heart Defects, Other · Completed
Key facts
| NCT number | NCT00266162 |
|---|---|
| Title | Bosentan in Treatment of Pulmonary Arterial Hypertension |
| Official title | Therapy of Pulmonary Arterial Hypertension (PAH) With Bosentan in Patients With Eisenmenger Syndrome |
| Lead sponsor | Competence Network for Congenital Heart Defects, Other |
| Collaborators | German Federal Ministry of Education and Research Actelion Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Eisenmenger Syndrome |
| Intervention type | Drug |
| Interventions | Bosentan administration |
| Enrollment | 60 |
| Start date | Aug 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Dec 16, 2005 |
| Last update posted | May 7, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: